Summary of thyroid and antithyroid drugs
-Introduction
-Synthesis
-Pharmacological Action
-Mechanism of action
-Drugs in Hypothyroidism
-Thyroid Inhibitors
-Drugs in Hyperthyroidism
Summary of thyroid and antithyroid drugs
-Introduction
-Synthesis
-Pharmacological Action
-Mechanism of action
-Drugs in Hypothyroidism
-Thyroid Inhibitors
-Drugs in Hyperthyroidism
A complete presentation on hypothroidism endocrine disorder based on latest editon of harrison and reference books. this presentation will help to learn about this second most common endocrine disorder.
Introduction:
@ Thyroid releases T3 & T4
@ The ratio of T4 to T3 is 5:1, so most of the hormone released is
thyroxine
@ Most of the T3 in the blood is derived from thyroxine
@ T3 is three to four times more potent than T4
@ The affinity of the receptor site for T3 is about ten times higher than that for T4
Introduction.
Biosynthesis
Types of Thyroid diseases
Thyroid Drugs
Antithyroid Drugs
Mechanism of action
Structure
Adverse Drug Reactions and Uses.
Reference
It Gives Information about Thyroid disease(its type), Thyroid Gland & Thyroid System. The Presentation also Give information on Hyperthyroidism ( like its Etiology, Symptoms, Diagnostic Evaluation and Treatment.
A power point presentation on thyroid hormones and thyroid inhibitors on subject of pharmacology suitable for reading by undergraduate medical students.
Thyroid and anti-thyroid drugs. Synthesis of thyroid hormoneAnkita
In this ppt we will get idea about thyroid and anti-thyroid drugs. how and where the thyroid hormone synthesis occur. regulation of thyroid hormone. get brief knowledge about anti-thyroid drugs, their action, MOA, adverse effect of anti-thyroid drugs and uses
The content of presentation is as follows
- introduction to thyroid
- thyroid hormone synthesis
- type of thyroidism
- difference between hyperthyroidism and hypothyroidism
-treatment of hypothyroidism
- anti thyroid drug classification
- mechanism of anti thyroid drugs
-
A complete presentation on hypothroidism endocrine disorder based on latest editon of harrison and reference books. this presentation will help to learn about this second most common endocrine disorder.
Introduction:
@ Thyroid releases T3 & T4
@ The ratio of T4 to T3 is 5:1, so most of the hormone released is
thyroxine
@ Most of the T3 in the blood is derived from thyroxine
@ T3 is three to four times more potent than T4
@ The affinity of the receptor site for T3 is about ten times higher than that for T4
Introduction.
Biosynthesis
Types of Thyroid diseases
Thyroid Drugs
Antithyroid Drugs
Mechanism of action
Structure
Adverse Drug Reactions and Uses.
Reference
It Gives Information about Thyroid disease(its type), Thyroid Gland & Thyroid System. The Presentation also Give information on Hyperthyroidism ( like its Etiology, Symptoms, Diagnostic Evaluation and Treatment.
A power point presentation on thyroid hormones and thyroid inhibitors on subject of pharmacology suitable for reading by undergraduate medical students.
Thyroid and anti-thyroid drugs. Synthesis of thyroid hormoneAnkita
In this ppt we will get idea about thyroid and anti-thyroid drugs. how and where the thyroid hormone synthesis occur. regulation of thyroid hormone. get brief knowledge about anti-thyroid drugs, their action, MOA, adverse effect of anti-thyroid drugs and uses
The content of presentation is as follows
- introduction to thyroid
- thyroid hormone synthesis
- type of thyroidism
- difference between hyperthyroidism and hypothyroidism
-treatment of hypothyroidism
- anti thyroid drug classification
- mechanism of anti thyroid drugs
-
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
2. Thyroid gland
One of largest endocrine glands in the body.
Site:
Located in the neck just below the larynx, on either side of
& anterior to the trachea.
3. Thyroid gland
Formed of 2 lobes (Rt & Lt), that are connected by
band of tissue called “isthmus”.
Not visible under normal conditions, but can be felt
during swallowing.
4. Thyroid gland structure
Follicles (Acini):
Are the functional unit.
Each follicle is spherical in structure &
filled with proteinaceous material
called colloid which contains large
glycoprotein called thyroglobulin
which stores thyroid hormones
within its molecules.
5. Thyroid gland secretions
- Secreted by Parafollicular cells.
- Important hormone for Ca2+ metabolism & homeostasis.
● 2 important thyroid hormones:
● Thyroxine (T4) or tetraiodothyronine
● Triiodothyronine (T3)
Secreted by Follicular cells.
Calcitonin
6. Chemical nature of thyroid hormones
I
HO
COOH
CH2-CH
O
T3 has : - 2 benzene rings
- 3 iodine atoms (contains 59% iodine)
- COOH & NH2 groups like an amino acid.
NH2
I
I
T4 has : - 2 benzene rings
- 4 iodine atoms (contains 65% iodine)
- COOH & NH2 groups like an amino acid.
O
I I
I
CH2-CH
HO
I
COOH
NH2
7.
8. 1-Uptake of Iodide:
Found in food in the form of “iodide (I-) is actively
transported (trap) into the follicle by a symporter or iodide
pump : Na+/ I- symporter (NIS)
2- Oxidation & Iodination/Organification:
• Conversion of the iodide ions to an oxidized form of iodine
by the enzyme peroxidase in presence of H2O2.
• Iodine immediately reacts with tyrosine residue on a
“thyroglobulin” to form MIT & DIT , called as
organification or iodination
Both processes are catalyzed by thyroidal peroxidase enzyme
10. 3- Condensation (coupling):
MIT & DIT or 2 DIT molecules coupled together, reaction
catalyzed by same peroxidase
MIT + DIT = T3
DIT + DIT = T4
T3 can also be formed by de-iodination of T4 by deiodinase
4- Proteolysis of Colloid &Thyroid hormones
secretion:
These hormones are released by exocytosis and proteolysis of
thyroglobulin.
11.
12. HORMONE TRANSPORT .
T4 and T3 are reversibly bound to thyroxine binding
globulin (TBG).
0.04% of total T4 and 0.4% of T3 exist in free form
Starvation , pregnancy , steroid hormones affects their
binding , but their free concentration is maintained in
euthyroid gland
13. PERIPHERAL METABOLISM
The primary pathway of peripheral T4 metabolism is
DEIODINATION.
Converstion of T4 in to T3.
14. MECHANISM OF ACTION
Free form of T3 and T4 enter cell by diffusion
/active transport .
T4 is converted to T3 & enters nucleus & binds to
T3 receptors, this leads to increased formation of
mRNA and subsequent protein synthesis.
15. THYROID REGULATION
Thyroid-pituitary relationship
Thyrotropin releasing hormone (TRH) is secreted by
hypothalamic cells in pituitary portal venous system.
It acts on pituitary, causes synthesis and release of thyroid
stimulating hormone (TSH).
This in turn acts on thyroid cells to increase release and
synthesis of T3 and T4.
Autoregulation of thyroid gland
17. Functions of thyroid hormones
1. Increases metabolic rate. Stimulates increased
consumption of glucose, fatty acids and other
molecules.
2. Increases metabolic heat, by mitochondrial no. &
activity ATP
3. Stimulates rate of cellular respiration by:
Production of uncoupling proteins.
Stimulates O2 consumption of most of cells in
the body.
18. Functions of thyroid hormones
4. Necessary for normal growth & maturation.
5. Promotes maturation of nervous system.
6. Promotes development of skeletal & reproductive
tissues
7. Stimulates protein synthesis.
8. Help regulating lipid & CHO metabolism.
19. Thyroid preparations
LEVOTHYROXINE:(T4)
This is the preparation of choice for thyroid replacement &
suppression therapy, because it is stable, content uniform,
lack allergenic protein, easy lab measurement of serum
levels, low cost and has a long (7 days) half life, to be
administered once daily.
T4 converted to T3 , so its administration produces both
hormones.
20. LIOTHYRONINE(T3):
More potent (3-4 times) & rapid acting than
levothyroxine but has a short half life (24 hours) &
costly as compared to levo, is not recommended for
routine replacement therapy, as it requires multiple
dosing in a day. Also difficult lab monitoring and
more risk of cardiotoxicity.
26. Mechanism of Action
They act by:
Inhibits organification and coupling reaction.
Propylthiouracil also inhibits the peripheral conversion
of T4 to T3.
27.
28. .
Pharmacokinetics:
Well absorbed orally, distributed all over the body
Methimazole long duration once-daily
Carbimazole is a pro-drug converted in the liver to its active
metabolite methimazole.
Serum half life: 90mins(PTU) ; 6 hours (methimazole)
Excretion: kidney – 24 hours (PTU) ; 48 hours
(Methimazole)
Can cross placental barrier (lesser with PTU)
Methimazole 10x more potent than PTU
PTU more protein-bound
29. Adverse Effects
GIT distress, nausea are earlier effects.
Maculopapular rash & fever.
Rare : Urticarial rash, vasculitis, arthralgia
,cholestatic jaundice, lymphadenopathy, &
hypoprothrombenemia.
Altered sense of taste or smell & cholestatic
jaundice with methimazole
Severe hepatitis with PTU
Most dangerous complication is agranulocytosis ,
infrequent but may be fatal.
30. IODIDES
Lugol's solution (5 % iodine + 10 % potassium iodide) 3-5
drops orally tid.
Potassium iodide 1-3 drops orally tid.
Mechanism of action:
Inhibit organification
block the effect of TSH on the thyroid gland, so decrease the
size & vascularity.
31.
32. Toxicity:
Overdoses of iodine may cause iodism (metallic
taste, excessive salivation, with painful salivary
gland, diarrhea, productive cough, running eyes &
nose, sore throat and rashes; mimic chicken-pox).
Iodine therapy maximizes iodine stores in the
thyroid. This effect delays the response to
thionamides.
33. RADIOACTIVE IODINE
The beta radiations of 1131 destroy thyroid parenchyma,
so decreasing hormonal release.
Advantages:
Easy administration (orally).
Effectiveness.
Absence of pain
It is not expensive.
Suitable for old ages and cardiac patients with
moderate to severe hyperthyroidism and unfit for
surgery.
34. Adverse effects:
As with iodine therapy, overdoses may cause iodism.
Local pain & congestion at the site of the gland.
Permanent Hypothyroidism.
Malignant changes in the thyroid after many years
Contraindications:
Pregnancy, children , nursing mother & under the age of 20
years
35. receptor blockers
•Control manifestations of sympathetic over activity
•It decreases the peripheral conversion of T4 to T3
36. ANION INHIBITORS
Perchlorate (ClO4
-) ; pertechnetate(TcO4
-) &
thiocynate (SCN-) block uptake of iodide by the
gland by competitive inhibition
Can be overcome by large doses of iodides
They are rarely used clinically now days as they
cause aplastic anemia.
37.
38. HYPOTHYRODISM
It is a syndrome resulting from deficiency of thyroid
hormones and manifested by reversible slowing down of all
body function.
Infants and children suffer severely , results in dwarfism
and irreversible mental retardation
Diagnosed by low free thyroxine and elevated serum TSH
For treatment : replacement therapy is appropriate
Levothyroxine is most satisfactory: Infants and children
require more T4 / kg body weight than adults.
39. 39
Thyroxine is given once daily due to long half life.
In older patients and in patients with underlying cardiac
diseases treatment is started with reduced dose
levothyroxine (T4) is given in a dose of 12.5 – 25 µg/day
for two weeks and then increasing it after every two weeks.
40. ADVERSE EFFECTS OF OVER DOSE OF
THYROXINE
CHILDEREN : Restlessness, insomnia, accelerated
bone maturation.
ADULTS : Nervousness, heat intolerance ,
palpitation, weight loss
Atrial fibrillation and osteoporosis in chronic over
treatment with T4.
41. MYXEDEMA COMA
It is an end state of untreated hypothyroidism.
Serious medical emergency, mortality rate high (60%)
despite early diagnosis and treatment.
Profound hypothermia, respiratory depression,
unconscious, bradycardia, delayed reflexes, dry skin.
The treatment of choice is loading dose of levothyroxine
I/V 300-400µg initially followed by 50-100mcg daily.
I/V T3 can be used but it may prove cardiotoxic
I/V hydrocortisone it may be used in case of adrenal and
pituitary insufficiency.
42. HYPOTHYROIDSM AND
PREGNANCY
These woman suffer form anovulatory cycles and
infertility
In pregnant hypothyroid patient 20-30 % increase
in thyroxine is required because of
elevated maternal TBG and
early development of fetal brain which depends
on maternal thyroxine
43. HYPERTHYROIDISM
This is the syndrome that results when tissue is
exposed to high levels of thyroid hormone.
GRAVES' DISEASE
Most common form of hyperthyroidism.
It is autoimmune disorder
There is genetic defect
antibodies against thyroid antigens.
T3 and T4 are elevated and TSH is suppressed.
44. Management of Grave’s disease
Drug therapy
Surgical thyroidectomy
Destruction of the gland with radioactive iodine
45. Drug therapy:
When patient is young with small gland and mild
disease
Methimazole / propylthiouracil until disease undergoes
spontaneous remission.
This may take 1-2 years with 60-70 % relapse.
46. THYROIDECTOMY
A near-total thyriodectomy is the treatment of choice in
very large gland or multinodular goiter
47. RADIOACTIVE IODINE 131I
Preferred in most patients over 21 years of age.
In patients with underlying heart disease, severe disease &
in elderly patient use methimazole until patient become
euthyroid , then stop the medicine for 5-7 days before
giving 131I
Major complication of this therapy is hypothyroidism which
occurs in 80% of patients.
48. Adjunct Therapy
During acute phase β-blockers without intrinsic
sympathomimetic activity are extremely helpful eg
: Propranolol
Diltiazem 90-120 mg TDS, when β-blockers
contraindicated
Barbiturates
Cholestyramine
49. THYROID STORM
It is sudden acute exacerbation of all of the symptoms of
thyrotoxicosis, presenting as a life threatening syndrome.
There is hyper metabolism, and excessive adrenergic
activity, death may occur due to heart failure and shock.
Vigorous management is mandatory.
50. Propranolol 1-2mg slow I/V or 40-80 mg orally every 6
hours
Potassium iodide 10 drops orally daily or
Iodinated contrast media (Na ipodate 1 g orally daily)
Propylthiouracil 250 mg orally every six hours or 400 mg
every six hours rectally.
Hydrocortisone 50 mg I/V every 6 hours to prevent shock.
If above methods fail plasmapheresis or peritoneal dialysis.
51. Thyrotoxicosis during pregnancy
Definitive therapy with 131I or subtotal thyroidectomy prior
to pregnancy to avoid acute exacerbation during pregnancy
or after delivery
During pregnancy radioiodine is contraindicated.
Propylthiouracil is better choice during pregnancy. Dose
must be kept minimum i.e., <300 mg daily.